Parliamentary questions can be asked by any MSP to the Scottish Government or the Scottish Parliamentary Corporate Body. The questions provide a means for MSPs to get factual and statistical information.
Urgent Questions aren't included in the Question and Answers search. There is a SPICe fact sheet listing Urgent and emergency questions.
Displaying 48973 questions Show Answers
To ask the Scottish Government what assessment it has made of the dangers of vape spiking, and whether this may differ compared to other means of spiking.
To ask the Scottish Government what assessment it has made of the prevalence of vape spiking, and how this compares to other means of spiking.
To ask the Scottish Government what impact assessment was conducted regarding the £12 million reduction to the “Travel Strategy and Innovation” budget line in its Budget 2024-25.
To ask the Scottish Government how many times intrauterine devices have been prescribed to prisoners in the female prison estate in each of the last five years, broken down by type of device.
To ask the Scottish Government how many trans (a) women and (b) men have (i) requested and (ii) undergone gender reassignment surgery while in prison in each of the last five years.
To ask the Scottish Government what impact assessment was conducted regarding the £63.4 million reduction to the “Future Transport Fund – Low Carbon” budget line in its Budget 2024-25.
To ask the Scottish Government, further to the answer to question S6W-24240 by Fiona Hyslop on 19 January 2024, what assessment has been made of the potential impact that heavier electric vehicles will have on the vehicle carrying capacity of CalMac's ferry fleet.
To ask the Scottish Government what role it considers demand responsive transport planning will play in delivering its target of a 20% reduction in car kilometres travelled by 2030.
To ask the Scottish Government whether it will provide an update on what action it is taking to increase capacity in hospices.
To ask the Scottish Government what steps it (a) can take and (b) is taking to prevent the (i) sale and (ii) use of unregulated products in aesthetic treatments.